Additionally, in phase 2 studies in people with MASH and liver fibrosis, survodutide not only significantly improved liver steatosis, but also led to histologic improvement of MASH without worsening fibrosis in 4362% of participants, versus 14% with placebo [41]
10.1146/annurev.pa.25.040185.003435 Ann Rev Pharmacol Toxicol
doi: 10.1530/JOE-17-0680 70 LiuXMChanHCDingGLCaiJSongYWangTTet al
Because GLP-1 slows down digestion, some patients may experience mild gastrointestinal side effects like nausea, mild stomach discomfort, or changes in bowel habits, especially when first starting
This rare tumor was first described by Millar in 1932, as a "malignant melanotic tumor of the ganglion cells arising from the thoracic sympathetic ganglion." 13 It was later identified as a subtype of schwannoma in 1961 by Hodson 34 before subsequently being termed "melanocytic schwannoma" in 1975 by Fu et al
Hence, electrolyte leakage might be used to distinguish stress-susceptible and tolerant cultivars